These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29654295)

  • 1. Antihypertensive effect of etamicastat in dopamine D2 receptor-deficient mice.
    Armando I; Asico LD; Wang X; Jones JE; Serrão MP; Cuevas S; Grandy DK; Soares-da-Silva P; Jose PA
    Hypertens Res; 2018 Jul; 41(7):489-498. PubMed ID: 29654295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine β-hydroxylase inhibitor.
    Igreja B; Wright LC; Soares-da-Silva P
    J Am Soc Hypertens; 2016 Mar; 10(3):207-16. PubMed ID: 26803288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.
    Pires NM; Igreja B; Moura E; Wright LC; Serrão MP; Soares-da-Silva P
    Hypertens Res; 2015 Sep; 38(9):605-12. PubMed ID: 25854989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice.
    Armando I; Wang X; Villar VA; Jones JE; Asico LD; Escano C; Jose PA
    Hypertension; 2007 Mar; 49(3):672-8. PubMed ID: 17190875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat.
    Igreja B; Pires NM; Bonifácio MJ; Loureiro AI; Fernandes-Lopes C; Wright LC; Soares-da-Silva P
    Hypertens Res; 2015 Jan; 38(1):30-8. PubMed ID: 25298210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production.
    Yang Y; Cuevas S; Yang S; Villar VA; Escano C; Asico L; Yu P; Jiang X; Weinman EJ; Armando I; Jose PA
    Hypertension; 2014 Oct; 64(4):825-32. PubMed ID: 25024286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etamicastat, a new dopamine-ß-hydroxylase inhibitor, pharmacodynamics and metabolism in rat.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Igreja B; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2014 Oct; 740():285-94. PubMed ID: 25058908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etamicastat, a novel dopamine β-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension.
    Almeida L; Nunes T; Costa R; Rocha JF; Vaz-da-Silva M; Soares-da-Silva P
    Clin Ther; 2013 Dec; 35(12):1983-96. PubMed ID: 24296323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production.
    Cuevas S; Zhang Y; Yang Y; Escano C; Asico L; Jones JE; Armando I; Jose PA
    Hypertension; 2012 Feb; 59(2):446-52. PubMed ID: 22215708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice.
    Li XX; Bek M; Asico LD; Yang Z; Grandy DK; Goldstein DS; Rubinstein M; Eisner GM; Jose PA
    Hypertension; 2001 Sep; 38(3):303-8. PubMed ID: 11566895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dopamine receptors, oxidative stress, and hypertension.
    Cuevas S; Villar VA; Jose PA; Armando I
    Int J Mol Sci; 2013 Aug; 14(9):17553-72. PubMed ID: 23985827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Pires N; Igreja B; Wright LC; Soares-da-Silva P
    Xenobiotica; 2015; 45(9):828-39. PubMed ID: 25915108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure.
    Zhang Y; Cuevas S; Asico LD; Escano C; Yang Y; Pascua AM; Wang X; Jones JE; Grandy D; Eisner G; Jose PA; Armando I
    PLoS One; 2012; 7(6):e38745. PubMed ID: 22719934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Thioredoxin 1 in Impaired Renal Sodium Excretion of hD
    Wang S; Tan X; Chen P; Zheng S; Ren H; Cai J; Zhou L; Jose PA; Yang J; Zeng C
    J Am Heart Assoc; 2019 Apr; 8(8):e012192. PubMed ID: 30957627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.
    Wang X; Escano CS; Asico L; Jones JE; Barte A; Lau YS; Jose PA; Armando I
    Hypertension; 2013 Aug; 62(2):295-301. PubMed ID: 23753418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene.
    Gayen JR; Zhang K; RamachandraRao SP; Mahata M; Chen Y; Kim HS; Naviaux RK; Sharma K; Mahata SK; O'Connor DT
    Circ Cardiovasc Genet; 2010 Oct; 3(5):414-25. PubMed ID: 20729505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-β-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects.
    Nunes T; Rocha JF; Vaz-da-Silva M; Igreja B; Wright LC; Falcão A; Almeida L; Soares-da-Silva P
    Drugs R D; 2010; 10(4):225-42. PubMed ID: 21171669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine Receptor D
    Zeng C; Armando I; Yang J; Jose PA
    Yale J Biol Med; 2023 Mar; 96(1):95-105. PubMed ID: 37009199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.